Effects of linagliptin on renal endothelial function in patients with type 2 diabetes: a randomised clinical trial.
about
A randomised, active- and placebo-controlled, three-period crossover trial to investigate short-term effects of the dipeptidyl peptidase-4 inhibitor linagliptin on macro- and microvascular endothelial function in type 2 diabetes.Diabetes, hypertension, and chronic kidney disease progression: role of DPP4.The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin.The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptin.Effects of linagliptin on endothelial function and postprandial lipids in coronary artery disease patients with early diabetes: a randomized, placebo-controlled, double-blind trial.
P2860
Effects of linagliptin on renal endothelial function in patients with type 2 diabetes: a randomised clinical trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Effects of linagliptin on rena ...... : a randomised clinical trial.
@en
Effects of linagliptin on rena ...... : a randomised clinical trial.
@nl
type
label
Effects of linagliptin on rena ...... : a randomised clinical trial.
@en
Effects of linagliptin on rena ...... : a randomised clinical trial.
@nl
prefLabel
Effects of linagliptin on rena ...... : a randomised clinical trial.
@en
Effects of linagliptin on rena ...... : a randomised clinical trial.
@nl
P2093
P2860
P1433
P1476
Effects of linagliptin on rena ...... : a randomised clinical trial.
@en
P2093
Carsten Willam
Christian Ott
Iris Kistner
Mirjam Keller
Roland E Schmieder
Stefanie Friedrich
P2860
P2888
P304
P356
10.1007/S00125-016-4083-4
P577
2016-09-01T00:00:00Z